64 Results for "

glucokinase

" in MedChemExpress (MCE) Product Catalog:
Products (64)

64 Results for "glucokinase" in MCE Product Catalog:

Cat. No.: HY-P2761
CAS No.: 9001-36-9
Research Areas:  

Metabolic Disease

Glucokinase is a glucose-phosphorylating enzyme that has an important role in glucose homeostasis. Glucokinase acts as a glucose sensot of pancreatic β-cells. Glucokinase regulates the conversion of glucose to glucogen as well as gluconeogenesis. Glucokinase in mammals can phosphorylate hexoses like mannose or fructose in addition to glucose. Glucokinase can be studied in research on diabetes .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-109030
CAS No.: 1191995-00-2
Purity:  99.87%
Synonyms: HMS5552
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Dorzagliatin (HMS5552), a dual-acting glucokinase (GK) activator, improves glycaemic control and pancreatic β-cell function in type 2 diabetes .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10595
CAS No.: 300353-13-3
Purity:  99.95%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

RO-28-1675 is a potent allosteric glucokinase (GK) activator with an EC50 of 54 nM. RO-28-1675 can be used for the research of type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W040127
CAS No.: 6906-39-4
Peonidin 3-O-glucoside chloride is an agonist of the free fatty acid receptor FFAR1 and Glucokinase. Peonidin 3-O-glucoside chloride enhances insulin secretion of pancreatic beta cells and increases glucose uptake by liver cells. Peonidin 3-O-glucoside chloride activates FFAR1, promotes the phosphorylation of related proteins in the insulin secretion pathway, and increases the expression of FFAR1. In liver cells, Peonidin 3-O-glucoside chloride activates GK and regulates proteins associated with carbohydrate metabolism. Peonidin 3-O-glucoside chloride can be used in diabetes research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13529
CAS No.: 1234703-40-2
Purity:  ≥98.0%
Synonyms: LY2608204; SY-004
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Globalagliatin (LY2608204) is an orally active glucokinase (GK) activator with an EC50 of 42 nM. Globalagliatin also stimulates glucose metabolism in rat insulinoma INS1-E cells with an EC50 of 579 nM. Globalagliatin targets both pancreatic β-cells and hepatocytes. Globalagliatin is promising for research of type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12411
CAS No.: 1361224-53-4
Purity:  99.62%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

AMG-3969 is a potent glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor with an IC50 of 4 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112253A
CAS No.: 71662-09-4
D-Fructose 1-phosphate disodium is a key intermediate metabolite in the fructose metabolic pathway. As a key signaling molecule linking fructose metabolism and glucose metabolic regulation, D-Fructose 1-phosphate disodium acts as an allosteric modulator to counteract the inhibitory effect of the glucokinase-regulatory protein complex, thereby finely regulating the direction of hepatic glucose metabolism at the substrate level .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100221
CAS No.: 1442684-77-6
Purity:  99.30%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

AM-2394 is a structurally distinct glucokinase activator (GKA). AM-2394 activates glucokinase (GK) with an EC50 of 60 nM.
loading...
    loading...
Cat. No.: HY-42680
CAS No.: 87-81-0
Synonyms: D-(-)-Tagatose
D-Tagatose (D-(-)-Tagatose) is a natural low-calorie rare sugar. D-Tagatose inhibits the activities of sucrase, maltase and intestinal disaccharidases, reduces the digestion of sucrose and starch, and blocks the absorption of sucrose, maltose and glucose. D-Tagatose promotes glucokinase activity and inhibits glycogen phosphorylase activity via tagatose-1-phosphate, regulates the synthesis and decomposition of hepatic glycogen, reduces postprandial and fasting blood glucose levels, and improves hyperinsulinemia. D-Tagatose regulates lipid profiles, stimulates GLP-1 secretion, and exhibits prebiotic effects. D-Tagatose is a bulking sweetener. D-Tagatose can be used in research related to diabetes, hyperlipidemia, dental caries, atherosclerosis and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-108328
CAS No.: 1245603-92-2
Purity:  99.94%
Synonyms: PF-04937319
Target:  

Glucokinase

Nerigliatin (PF-04937319) is a orally active glucokinase activator (GKA) with EC50 value of 154.4 μM. Nerigliatin maintains glucose-lowering efficacy. Nerigliatin causes peripheral nerve degeneration. Nerigliatin can be used in type 2 diabetes research.
loading...
    loading...
Cat. No.: HY-15671
CAS No.: 851884-87-2
Purity:  99.57%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

GKA50 is a potent glucokinase activator (EC50=33 nM at 5 mM glucose). GKA50 stimulates insulin release from mouse islets of Langerhans. GKA50 is a glucose-like activator of beta-cell metabolism in rodent and human islets and a Ca 2+-dependent modulator of insulin secretion. GKA50 shows significant glucose lowering in high fat fed female rats .
loading...
    loading...
Cat. No.: HY-15675
CAS No.: 919783-22-5
Purity:  98.09%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

AZD1656 is a potent, selective and orally active glucokinase activator with an EC50 of 60 nM. AZD1656 has the potential for type 2 diabetes research .
loading...
    loading...
Cat. No.: HY-112253
CAS No.: 15978-08-2
D-Fructose 1-phosphate is a key intermediate metabolite in the fructose metabolic pathway. As a key signaling molecule linking fructose metabolism and glucose metabolic regulation, D-Fructose 1-phosphate acts as an allosteric modulator to counteract the inhibitory effect of the glucokinase-regulatory protein complex, thereby finely regulating the direction of hepatic glucose metabolism at the substrate level .
loading...
    loading...
Cat. No.: HY-19843
CAS No.: 1137916-97-2
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

MK-0941 is a selective, orally active, and allosteric glucokinase activator with EC50s of 240 and 65 nM for recombinant human glucokinase in the presence of 2.5 and 10 mM glucose, respectively. MK-0941 activates hexokinase subtype IV. MK-0941 can increase insulin secretion and glucose uptake. MK-0941 can be studied in research for type 2 diabetes .
loading...
    loading...
Cat. No.: HY-100181
CAS No.: 1215197-37-7
Purity:  99.42%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

PF-04991532 is a potent, hepatoselective glucokinase activator with EC50s of 80 and 100 nM in human and rat, respectively.
loading...
    loading...
Cat. No.: HY-147254
CAS No.: 859525-02-3
Purity:  99.80%
Synonyms: TTP-399
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-131940
CAS No.: 94825-74-8
Purity:  ≥95.0%
Synonyms: 3-O-Methyl-GlcNAc
Target:  

Insecticide

Research Areas:  

Metabolic Disease

3-O-Methyl-N-acetyl-D-glucosamine is a potent inhibitor of N-acetylglucosamine kinase. 3-O-Methyl-N-acetyl-D-glucosamine potently inhibits glucose phosphorylation by N-acetylglucosamine kinase whereas glucokinase is not at all affected by this hexosamine .
loading...
    loading...
Cat. No.: HY-P11060
Synonyms: Adpgk peptide
Target:  

MHC

Research Areas:  

Cancer

MC38 SLP Adpgk (Adpgk peptide) is an H-2 K b-restricted colorectal cancer neoantigen peptide. MC38 SLP Adpgk is formulated into PCNP nanocomplexes together with CpG ODN. PCNP vaccines significantly enhance the co-delivery efficiency of neoantigens and adjuvants to lymphoid organs, and activate cytotoxic T cells. PCNP vaccines not only protect mice from MC-38 colorectal tumor invasion, but also exhibit anti-tumor efficacy in established colorectal tumor models and significantly prolong the survival of tumor-bearing mice .
loading...
    loading...
Cat. No.: HY-144287
CAS No.: 1001417-92-0
Purity:  98.36%
Research Areas:  

Metabolic Disease

Glucokinase activator 3 is an orally active Glucokinase (GK) activator with an AC50 of 38 nM. Glucokinase activator 3 inhibits hERG channel and sodium channel in patch clamp assays. Glucokinase activator 3 exhibits high efficacy in reducing blood glucose in diet-induced obese (DIO) mice. Glucokinase activator 3 has the potential for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-133127
CAS No.: 1065609-00-8
Purity:  99.84%
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

AR453588 is a potent and orally bioavailable anti-diabetic glucokinase activator, with an EC50 of 42 nM. AR453588 shows anti-hyperglycemic activity .
loading...
    loading...